Securities code: 688575 securities abbreviation: Shenzhen Yhlo Biotech Co.Ltd(688575) Announcement No.: 2022-015 Shenzhen Yhlo Biotech Co.Ltd(688575)
Self inspection report on the trading of the company’s shares by insiders and incentive objects of the restricted stock incentive plan in 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law. Shenzhen Yhlo Biotech Co.Ltd(688575) (hereinafter referred to as “the company”) held the third meeting of the third board of directors and the third meeting of the third board of supervisors on January 14, 2022, deliberated and adopted the proposal on the company’s restricted stock incentive plan in 2022 (Draft) > and its summary, and posted it on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 15, 2022 Relevant announcements were disclosed.
In accordance with the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “measures”), the Listing Rules of Shanghai Stock Exchange on the science and innovation board, the self regulatory guide for listed companies on the science and Innovation Board No. 4 – disclosure of equity incentive information and other laws, regulations and normative documents, as well as the relevant provisions of the company’s information disclosure management system, Within 6 months before the public disclosure of the draft incentive plan, the company provided insider information and incentive objects of the 2022 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) to China Securities Depository and Clearing Co., Ltd. Shanghai Branch, That is, from July 15, 2021 to January 14, 2022 (hereinafter referred to as the “self inspection period”), the company conducted a self inspection on the purchase and sale of the company’s shares. The details are as follows:
1、 Scope and procedure of verification
1. The verification objects are insiders of the incentive plan and all incentive objects (hereinafter referred to as “verification objects”).
2. Insiders of the incentive plan filled in the registration form of insiders.
3. The company inquired and confirmed with the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. about the purchase and sale of the company’s shares during the self inspection period, and the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. issued the inquiry certificate.
2、 Description of the purchase and sale of the company’s shares by the verification object
Serial number name trading range total buy (shares) total sell (shares)
1 min Liangliang 2021.07.30-2022.01.14 4200 6300
2 Li Qiang 2021.07.16 0 400
3 Qiu Huanjie from July 15, 2021 to December 08, 2021 3700 1000
4 Chen Jifan from August 27, 2021 to November 25, 2021 1418 1418
5 Zhou Yi, August 24, 2021-september 17, 2021 1400 2200
6 Li Xuejin from August 31, 2021 to October 27, 2021 200
According to the records of the above verification objects’ buying and selling of the company’s shares, and in combination with the relevant processes of the company’s planning and implementation of this incentive plan, the company has verified the behavior of the above personnel in buying and selling the company’s shares:
After verification, the stock trading conducted by the above verification objects during the self inspection is based on the individual’s independent judgment on the trading situation of the secondary market. Before buying and selling the company’s shares, they do not know the specific scheme elements and other relevant information of the equity incentive plan, and there is no case of using the relevant insider information of the incentive plan to conduct the company’s stock trading.
3、 Conclusion
According to the regulations of the company’s internal confidential plan and management mechanism, the scope of the company’s internal confidential personnel to participate in the planning process is strictly limited, and the company’s internal confidential personnel are strictly registered in accordance with the provisions of the company’s internal confidential plan and management mechanism.
After verification, within six months before the public disclosure of the draft incentive plan, no insider and incentive object of the incentive plan were found to have used the company’s 2022 restricted stock incentive plan for stock trading or disclosed the incentive plan’s insider information.
It is hereby announced.
Shenzhen Yhlo Biotech Co.Ltd(688575) board of directors February 8, 2022
